Astellas Pharma AG - Advagraf 5 mg, Retardkapseln | | 58809 | | 03 | | Advagraf 5 mg | | Retardkapseln | | L04AD02 | | Tacrolimus | | 16.03.2012 | | |
| Composition | tacrolimusum 5 mg, hypromellosum, ethylcellulosum, lactosum monohydricum 536.4 mg, magnesii stearas, Kapselhülle: gelatina, E 171, E 172 (flavum), E 172 (rubrum), natrii laurilsulfas corresp. natrium 200 ppm, Drucktinte: lacca, lecithinum ex soja, simeticonum, hydroxypropylcellulosum, E 172 (rubrum), pro capsula. | Packungsbestandteile | | Delayed release capsules | | | Active Agent | Dose |
---|
Tacrolimus | 5 mg |
| BAG: Active Agent | Dose |
---|
Tacrolimus | 5 mg |
| | Inactive agents | Dose | additional_information |
---|
(Flavum) | | | (Rubrum) | | | E 171 | | color. | E 172 | | color. | Ethylcellulosum | | | Gelatina | | Kapselhülle | Hydroxypropylcellulosum | | | Hypromellosum | | | Lacca | | Drucktinte | Lactose Monohydrate | 536.4 mg | | Lecithinum ex Soja | | | Magnesii Stearas | | | Natrii Laurilsulfas | | | Ppm | | | Pro Capsula | | | Simeticone | | |
| |
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
---|
008 | 50 Capsule(s) | 513.52 | 574.90 | A | SL | Yes |
|
|